JNJ’s CEO Weldon May Send Underling to Congress. The Aching Back Excuse
I just learned that Bill Weldon, JNJ's CEO, who was asked to testify at a May 27 hearing of the House Committee on Oversight and Government Reform about the McNeil manufacturing...
Will 250,000 Morbidly Obese People Sign Allergan’s Petition to Congress?
"Be heard!", says Allergan. "The voices of 250,000 can influence the dialogue on the obesity epidemic and help shape policies that can make a real difference in our efforts to reduce...
Despite Its Social Media Expertise, J&J Fails to Use It Effectively to Communicate to...
Johnson & Johnson's (JNJ's) has earned accolades from industry pundits for its social media expertise (see Dosie Awards, for example). Yet it's handling of the McNeil Consumer recall of children's medicines...
Equation Proves that Broadcast DTCA Only a Minor Contributor to Growth in Rx Drug...
In an equation that Einstein would be proud of, researchers at the National Bureau of Economic Research (NBER) supported by a grant from the Agency for Healthcare Research and Quality have...
Should Google Allow Pharma an Exception to Its Ban on Redirect URLs? (UPDATED)
Back in April 2009, I suggested that FDA might go after pharma marketers for using paid search redirects in Google Adwords (see "The Next FDA Concern May be the Use of...
Will FDA Cite this Vyvanse Web Image as Off-Label Promotion?
If an image is worth a thousand words, then this image found on the Vyvanse Web site home page is shouting off-label promotion.
Is it a coincidence that this image, showing a...
Pharma Marketing Meets Social Media: Can the Two Co-Habitate?
I am taking a short vacation in Miami and will be chairing the Pharmaceutical Marketing Innovation Summit, May 10 - 12, 2010 at the Doral Golf Resort & Spa. I will...
Trouble in the House that McNeil Built: Why Drug Company Silos are Useful
Marc Monseau, head of corporate communications at Johnson & Johnson (J&J or JNJ) and contributor to the JNJBTW Blog, often says that JNJ is not a pharmaceutical company. He likes to...
Is Your Brand a Digital Genius or a Feeble-Minded Idiot?
When it comes to digital IQ, some brands are geniuses and some are feeble-minded idiots, according to the "L2 Digital IQ Index" for pharmaceutical brands, a first-of-its kind measurement of the...
NAMI’s Pharma Funders – Serial Off-label Promoter Astrazeneca Tops the List
The National Alliance on Mental Illness (NAMI) until recently was reluctant to reveal the source of its funding. But thanks to Sen. Grassley we now can learn NAMI's sources for Major...
